An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
With spring come ticks and allergies: How to stay safe and healthy
- blkalertshealth
- April 14, 2024
- 0
From managing seasonal allergies to avoiding tick
The states where private equity has the most sway over housing, health care, jobs and pensions
- blkalertshealth
- April 10, 2024
- 0
A new study by Private Equity Stakeholder Project
Desperate for heart surgery for their baby, a family feels the effects of pediatric hospital shortages
- blkalertshealth
- March 21, 2024
- 0
Even before their daughter was born in June, Aaron